US Health Authorities Review Safety of COVID Vaccines in Pregnant Women and Children
U.S. health officials are reviewing safety data on COVID-19 vaccines for pregnant women and children, amid ongoing discussions and studies on vaccine safety and potential risks. The evaluation aims to ensure public health safety and may influence future vaccination guidelines.
Federal health officials in the United States are currently evaluating safety data concerning COVID-19 vaccines administered to pregnant women and children. This review comes amid ongoing discussions about the vaccine's safety profile in these vulnerable populations. The U.S. Food and Drug Administration (FDA) is specifically analyzing reports of potential birth defects observed after vaccination during pregnancy and is preparing a presentation on pediatric deaths potentially linked to COVID vaccination.
The upcoming meeting with the CDC's vaccine advisory committee is scheduled for September 18 and 19, marking a critical step in assessing the current evidence. While investigating, experts emphasize that the main tool used—the Vaccine Adverse Event Reporting System (VAERS)—is primarily designed to identify potential safety signals rather than establish causality. Dr. Demetre Daskalakis, former director of the CDC's National Center for Immunization and Respiratory Diseases, clarified that VAERS generates hypotheses that require further study.
Large-scale studies, including monitoring over 23,000 pregnant women in one registry and more than 45,000 in another database, have so far indicated no increased risk of major birth defects, miscarriages, or other adverse pregnancy outcomes linked to COVID vaccines. Pfizer also reported that in clinical trials involving pregnant women, the rate of birth defects in vaccinated individuals was comparable to the general population.
FDA Commissioner Dr. Marty Makary has stated that the agency intends to release all safety data transparently to the medical community to address public concerns. Additionally, there is discussion about potentially updating vaccination guidelines for older adults, possibly recommending booster shots predominantly for those aged 75 and above, or for younger individuals with underlying health conditions. Currently, COVID vaccines are approved for adults 65 and older and for high-risk younger adults.
For further insights, the New England Journal of Medicine offers detailed information on COVID vaccine recommendations. Overall, health authorities continue to monitor and analyze the safety evidence to guide vaccination policies and reassure the public.
Source: https://medicalxpress.com/news/2025-09-covid-vaccine-safety-pregnancy-kids.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Can Exercise Reprogram Genes to Combat Colon Cancer?
New research indicates that regular exercise may influence gene activity in colon cancer tumors and surrounding fat tissue, potentially offering a novel approach to cancer treatment and prevention.
Use of NRTIs Associated with Increased Risk of Primary Open-Angle Glaucoma
Recent research associates nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) with an increased risk of primary open-angle glaucoma, emphasizing the importance of eye monitoring for patients on these medications.
Aligning Surgical Decisions with Older Adults' Goals to Improve Patient-Centered Care
A groundbreaking decision-making tool helps align surgical choices with older adults' personal health goals, promoting patient-centered care and improved outcomes.